Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19667106rdf:typepubmed:Citationlld:pubmed
pubmed-article:19667106lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:19667106lifeskim:mentionsumls-concept:C0085201lld:lifeskim
pubmed-article:19667106lifeskim:mentionsumls-concept:C0132326lld:lifeskim
pubmed-article:19667106lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:19667106lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:19667106lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:19667106lifeskim:mentionsumls-concept:C0065055lld:lifeskim
pubmed-article:19667106pubmed:issue9lld:pubmed
pubmed-article:19667106pubmed:dateCreated2009-8-20lld:pubmed
pubmed-article:19667106pubmed:abstractTextThe purpose of this study was to investigate the mechanism by which the nonnucleoside reverse transcriptase inhibitor (NNRTI) nevirapine (NVP) increases high-density lipoprotein cholesterol (HDLc) in treatment-experienced human immunodeficiency virus-1 (HIV-1)-infected patients.lld:pubmed
pubmed-article:19667106pubmed:languageenglld:pubmed
pubmed-article:19667106pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19667106pubmed:citationSubsetIMlld:pubmed
pubmed-article:19667106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19667106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19667106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19667106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19667106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19667106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19667106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19667106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19667106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19667106pubmed:statusMEDLINElld:pubmed
pubmed-article:19667106pubmed:monthSeplld:pubmed
pubmed-article:19667106pubmed:issn1524-4636lld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:SauerweinHans...lld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:ReissPeterPlld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:BrinkmanKeesKlld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:StroesErik...lld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:AckermansMari...lld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:KasteleinJohn...lld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:Arenas-PintoA...lld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:HassinkEllyElld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:SankatsingRaa...lld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:FranssenRemco...lld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:HuttenBarbara...lld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:OesterholtRen...lld:pubmed
pubmed-article:19667106pubmed:authorpubmed-author:StorferStephe...lld:pubmed
pubmed-article:19667106pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19667106pubmed:volume29lld:pubmed
pubmed-article:19667106pubmed:ownerNLMlld:pubmed
pubmed-article:19667106pubmed:authorsCompleteYlld:pubmed
pubmed-article:19667106pubmed:pagination1336-41lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:meshHeadingpubmed-meshheading:19667106...lld:pubmed
pubmed-article:19667106pubmed:year2009lld:pubmed
pubmed-article:19667106pubmed:articleTitleNevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production.lld:pubmed
pubmed-article:19667106pubmed:affiliationDepartment of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.lld:pubmed
pubmed-article:19667106pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19667106pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:19667106pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19667106pubmed:publicationTypeMulticenter Studylld:pubmed
entrez-gene:335entrezgene:pubmedpubmed-article:19667106lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19667106lld:entrezgene